Martine P. Roudier

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

David M. Thomas, Robert M. Henshaw, Keith M. Skubitz et al. · The Lancet Oncology · 2010 · 703 citations

Bone Disease, Malignant Disease, Medicine +7

LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics

Holly M. Nguyen, Robert L. Vessella, Colm Morrissey et al. · The Prostate · 2017 · 307 citations · Full text

Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone

Martine P. Roudier, Lawrence D. True, Celestia S. Higano et al. · Human Pathology · 2003 · 306 citations

Urology, Genitourinary Cancer, Prostatic Disease +3

The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models

Stephen T. Durant, Li Zheng, Yingchun Wang et al. · Science Advances · 2018 · 292 citations · Full text

Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling

Lauren Brady, Michelle Kriner, Ilsa M. Coleman et al. · Nature Communications · 2021 · 290 citations · Full text